Viewing StudyNCT03095066



Ignite Creation Date: 2024-05-06 @ 9:53 AM
Last Modification Date: 2024-10-26 @ 12:21 PM
Study NCT ID: NCT03095066
Status: COMPLETED
Last Update Posted: 2023-09-29
First Post: 2017-03-23

Brief Title: Study to Assess the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression Agitation and Irritability in Participants With Traumatic Brain Injury
Sponsor: Otsuka Pharmaceutical Development Commercialization Inc
Organization: Otsuka Pharmaceutical Development Commercialization Inc

Organization Data

Organization: Otsuka Pharmaceutical Development Commercialization Inc
Class: INDUSTRY
Study ID: 17-AVP-786-205
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Otsuka Pharmaceutical Development Commercialization Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators